Mostrando 5 resultados de: 5
Filtros aplicados
Publisher
American Journal of Therapeutics(2)
Revista Latinoamericana de Hipertension(2)
Electronic Journal of Biotechnology(1)
Área de conocimiento
Enfermedad cardiovascular(3)
Medicina interna(2)
Biología molecular(1)
Bioquímica(1)
Cirugía(1)
Origen
scopus(5)
Increased levels of lipoprotein (a) are related to family risk factors of cardiovascular disease in children and adolescents from Maracaibo, Venezuela
ArticleAbstract: The aims of this study were to determine Lipoprotein (a) [Lp(a)] concentrations in a sample of subjePalabras claves:adolescents, CHILDREN, CVD risk factors, Family history, Lipoprotein (a)Autores:Almarza J., Cano-Peñaloza R., Cano-Ponce C., García-Camacho D., Hernández-Hernandez R., Israili Z.H., Mengual-Moreno E., Sorell L.T., Souki-Rincón A., Torres D., Urdaneta J., Valmore Bermúdez, Velasco M.Fuentes:scopusLipoprotein (a): Molecular and Epidemiologic basis about its role in cardiovascular diseases
ReviewAbstract: In 1963, Kare Berg at the University of Oslo discovered Lp(a) as a new human plasmatic antigen set.Palabras claves:Apolipoprotein(a), Atherogenesis, Cardiovascular disease, lipoprotein(a), Lp (a), thrombogenesisAutores:Aparicio D., Arráiz N., Canelón R., Cano-Ponce C., Cizcek A., Faria J., Gotera D., Guerra-Torres X.E., Manuel V., Rojas E.R., Sorell L.T., Valmore BermúdezFuentes:scopusLipoprotein(a): From molecules to therapeutics
ReviewAbstract: Lipoprotein (a) [Lp(a)] was discovered by Kare Berg in 1963 from the study of low-density lipoproteiPalabras claves:Atherogenesis, Cardiovascular disease, Hyperlipoproteinemia(a), lipoprotein(a), therapeuticsAutores:Amell A., Aparicio D., Arráiz N., Cabrera M., Canelón R., Cano R.A., Cano-Ponce C., Faria J., Gotera D., Guerra-Torres X.E., Mengual-Moreno E., Reyna-Villasmil N., Rojas E.R., Sorell L.T., Valmore Bermúdez, Velasco M.Fuentes:scopusUnusually elevated levels of lipoprotein(a) in Afro-American populations from south of Lake Maracaibo
ArticleAbstract: Objective. Lipoproteína(a), [Lp(a)], is an independent risk factor for coronary artery disease. In VPalabras claves:Apo(a), Cardiovascular disease, Lipoprotein (a), risk factorAutores:Amell A., Aparicio D., Cano-Ponce C., Faria J., Gotera D., Guerra-Torres X.E., Linares S., Medina M.T., Mengual-Moreno E., Nuñez M., Reyna-Villasmil N., Rojas E.R., Seyfi H.A., Sorell L.T., Souki-Rincón A., Valmore Bermúdez, Velasco M.Fuentes:scopusTherapeutic angiogenesis following intramuscular gene transfer of vascularendothelial growth factor 121 in a dog model of hindlimb ischemia
ArticleAbstract: Vascular endothelial growth factor (VEGF), an endothelial cell-specific mitogen, has been shown to pPalabras claves:Collateral development, Gene therapy, Naked plasmid DNA, Peripheral vascular disease, revascularizationAutores:Aldama A., Alfonso M.A., Alí A., Herrera L., López-Saura P.A., Montequín J.F., Ojalvo A.G., Puchades Y., Santiago Nelson Vispo, Seralena A., Seuc A., Silva R., Simón R., Sorell L.T., Vazquez R.Fuentes:scopus